An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for ...

Medicare will move ostomy supplies to eight national contracts in 2028. Survivors and clinicians say a poor fit can lead to ...

Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in ...

Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, ...

For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...

Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...

C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...

Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, ...

Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...

C, discusses why he built the MyUrova app and how men with prostate, bladder, kidney or testicular cancer can prepare for ...

The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...